RAS WILD TYPE

Clinical trials for RAS WILD TYPE explained in plain language.

Never miss a new study

Get alerted when new RAS WILD TYPE trials appear

Sign up with your email to follow new studies for RAS WILD TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

New drug combo shows promise in Hard-to-Treat colorectal cancer

Disease control Ongoing

This study tests whether combining two drugs, niraparib and panitumumab, can help control advanced colorectal cancer that has spread. About 26 adults whose cancer has not responded to at least one prior treatment will receive the combination. The goal is to see how many patients …

Matched conditions: RAS WILD TYPE

Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

RAS WILD TYPE

Get alerted when new RAS WILD TYPE trials appear

New drug combo shows promise in Hard-to-Treat colorectal cancer